Synergistic photodynamic therapy and IDO inhibition via a self-assembled nanomedicine potentiates PD-L1 blockade in gastrointestinal cancers
Biomaterials Advances · 2026-08 · 185 · 214849
DOI: 10.1016/j.bioadv.2026.214849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Advances, 2026-08. Verfasst von Yan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Fuzong Clinical College of Fujian Medical University, Fuzhou, 350025, China. Hauptthemen laut MEDLINE: Photochemotherapy, Nanomedicine, Gastrointestinal Neoplasms, Indoleamine-Pyrrole 2,3,-Dioxygenase. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Fujian Provincial Natural Science Foundation, National Natural Science Foundation of China, Fujian University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Tumor metastasis remains a major obstacle to achieving favorable prognosis and quality of life in patients with gastrointestinal cancers. Although immune checkpoint blockade (ICB) has shown potential in reducing metastatic risk, its efficacy largely depends on sufficient tumor-infiltrating T lymphocytes. Here, we developed a self-assembled nanomedicine (VN NPs) co-loaded with verteporfin and the IDO-1 inhibitor NLG919, using TPGS as a stabilizer and long-circulating agent. Upon intravenous administration, VN NPs preferentially accumulated in tumor tissue through passive targeting. Under light irradiation, verteporfin-induced photodynamic therapy triggered immunogenic cell death, promoted dendritic cell maturation, and initiated a systemic anti-tumor immune response. Simultaneously, NLG919 potently inhibited IDO-1 activity, blocking the conversion of tryptophan to kynurenine, thereby reversing local immunosuppression and synergizing with photodynamic immunotherapy. In murine models of gastric and colon cancer, this combination strategy not only suppressed primary tumor growth but also significantly inhibited distant metastasis in colon cancer. This simple yet effective nanoplatform amplifies ICB efficacy and represents a promising translational approach for metastatic gastrointestinal malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Fuzong Clinical College of Fujian Medical University, Fuzhou, 350025, China.
- Department of Multidisciplinary Oncology, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, 350005, China.
- School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
- Fujian Medical University Union Hospital, Fuzhou, 350001, China.
- Department of Oncology, Fuzong Clinical College of Fujian Medical University, Fuzhou, 350025, China. Electronic address: fuzhoucxi@163.com.
- Department of Hepatobiliary Disease, Fuzong Clinical College of Fujian Medical University, Fuzhou, 350025, China. Electronic address: ldliang900@163.com.
Förderung
- Fujian Provincial Natural Science Foundation
- National Natural Science Foundation of China
- Fujian University of Traditional Chinese Medicine
Zitieren
APA
Zhang, Y., Wu, J., Zhang, Q., Liang, P., Lin, Y., Yang, Z., Zheng, C., Chen, X., Li, D., & Feng, X. (2026). Synergistic photodynamic therapy and IDO inhibition via a self-assembled nanomedicine potentiates PD-L1 blockade in gastrointestinal cancers. Biomaterials Advances, 185, 214849. https://doi.org/10.1016/j.bioadv.2026.214849
Vancouver
Zhang Y, Wu J, Zhang Q, Liang P, Lin Y, Yang Z, et al. Synergistic photodynamic therapy and IDO inhibition via a self-assembled nanomedicine potentiates PD-L1 blockade in gastrointestinal cancers. Biomaterials Advances. 2026;185:214849. doi:10.1016/j.bioadv.2026.214849
BibTeX
@article{Zhang2026,
author = {Zhang, Yan and Wu, Jingjing and Zhang, Qi and Liang, Pingping and Lin, Yun and Yang, Zhirong and Zheng, Chen and Chen, Xi and Li, Dongliang and Feng, Xianquan},
title = {Synergistic photodynamic therapy and IDO inhibition via a self-assembled nanomedicine potentiates PD-L1 blockade in gastrointestinal cancers},
journal = {Biomaterials Advances},
year = {2026},
volume = {185},
pages = {214849},
doi = {10.1016/j.bioadv.2026.214849}
}
EUVIMED